Oral Treatments for Premature Ejaculation
Welcome to the Priligy information web site. Priligy (generic name dapoxetine), is a prescription medication used as treatment for premature ejaculation. Priligy has been clinically proven to extend the length of time of sexual intercourse by between 200% and 400%.
Priligy has been approved for sale in Finland, Sweden, Austria, Germany, Italy, Spain and Portugal and it is now approved in the UK and has gone on sale on private prescription.
Premature ejaculation is a very common condition, affecting in the region of 30% of men worldwide
Priligy can be prescribed for you if you are a male aged between 18 and 64 for the treatment of premature ejaculation.
Priligy in the UK, EU and US
Priligy has been approved for use by health authorities in Finland, Sweden, Austria, Germany, Italy, Spain and Portugal. It has also now been approved for use in the UK.
THE FDA (Food and Drug Administration) have not yet approved Priligy as a treatment for premature ejaculation. Approval was turned down in 2005. However, Johnson and Johnson will be discussing approval options with the U.S. Food and Drug Administration later this year (2009), according to Joanne Waldstreicher, the chief medical officer at Johnson and Johnson. Johnson and Johnson have conducted three additional late stage tests for safety and effectiveness, which have been completed since the 2005 rejection. The latest news is that Priligy is currently in Phase III of the US FDA approval process.
Priligy is prescribed for the treatment of premature ejaculation in men. It is not indicated for use by women.